BC Week In Review | Oct 10, 2011
Clinical News

CRD007: Completed Phase IIb enrollment

Cardoz completed enrollment of 326 patients in the double-blind, placebo-controlled, European Phase IIb AORTA trial evaluating 10, 25 and 40 mg oral CRD007. Cardoz AB , Stockholm, Sweden   Product: CRD007   Business: Cardiovascular   Molecular...
BC Week In Review | Jun 13, 2011
Clinical News

CRD007: Phase II started

Cardoz began the double-blind, placebo-controlled, European Phase II AORTA trial to evaluate 10, 25 and 40 mg oral CRD007 in 300 patients. Cardoz AB , Stockholm, Sweden   Product: CRD007   Business: Cardiovascular   Molecular target:...
Items per page:
1 - 2 of 2